Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: SACHI BIOWORKS, INC.
Awarding agency: National Aeronautics and Space Administration / National Aeronautics and Space Administration
Funding agency: National Aeronautics and Space Administration / National Aeronautics and Space Administration
Period of performance: 2024-03-18 to 2026-03-17
Current total value of award: $2234767
Description: SBIR PHASE III - REVERSING IMMUNE DYSREGULATION DURING SPACEFLIGHT MISSIONS